Compare Ingersoll Rand (IR) vs Nuvation Bio Inc. Class A Common Stock (NUVB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ingersoll Rand vs Nuvation Bio Inc. Class A Common Stock — how do they compare? Ingersoll Rand trades at $78.72 (market cap $30.26B), while Nuvation Bio Inc. Class A Common Stock trades at $5.07 (market cap $1.74B). The key difference: Ingersoll Rand is far larger — about 17.4× Nuvation Bio Inc. Class A Common Stock's market cap, and Ingersoll Rand pays a 0.1% dividend while Nuvation Bio Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Ingersoll Rand for 8 Days and Nuvation Bio Inc. Class A Common Stock for 1 Days on average.
| IR | NUVB | |
|---|---|---|
Market Cap | $30.26B | $1.74B |
Volume | 4,017,622 | 9,289,619 |
Sector | Industrials | Health |
52-Week High | $98.76 | $9.54 |
52-Week Low | $68.54 | $3.41 |
Typical Hold Time | 8 Days | 1 Days |
Enterprise Value | $33.92B | $1.33B |
Dividend Yield | 0.1% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Ingersoll Rand
Ingersoll Rand develops industrial technologies for creating and managing flow, pressure, and motion. Its portfolio includes compressors, pumps, vacuum systems, and other equipment used across industrial markets.
Read more on IR →About Nuvation Bio Inc. Class A Common Stock
Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.
Read more on NUVB →
